Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Net Margin: 2019-2023

Historic Net Margin for Benitec Biopharma (BNTC) over the last 2 years, with Jun 2023 value amounting to -65,114.29%.

  • Benitec Biopharma's Net Margin was N/A to -65,114.29% in Q2 2023 from the same period last year, while for Jun 2023 it was -15,539.84%, marking a year-over-year change of. This contributed to the annual value of -26,082.67% for FY2023, which is 158130.00% down from last year.
  • Benitec Biopharma's Net Margin amounted to -65,114.29% in Q2 2023, which was down 708.69% from -8,051.85% recorded in Q1 2023.
  • In the past 5 years, Benitec Biopharma's Net Margin registered a high of 8,220.00% during Q2 2020, and its lowest value of -379,500.00% during Q1 2021.
  • For the 3-year period, Benitec Biopharma's Net Margin averaged around -101,745.00%, with its median value being -40,135.71% (2022).
  • Its Net Margin has fluctuated over the past 5 years, first slumped by 37,201,786bps in 2021, then soared by 37,227,083bps in 2022.
  • Over the past 5 years, Benitec Biopharma's Net Margin (Quarterly) stood at -2,719.48% in 2019, then plummeted by 32,338,052bps to -326,100.00% in 2020, then skyrocketed by 30,671,600bps to -19,384.00% in 2021, then plummeted by 2,075,171bps to -40,135.71% in 2022, then tumbled by 82,269bps to -65,114.29% in 2023.
  • Its Net Margin stands at -65,114.29% for Q2 2023, versus -8,051.85% for Q1 2023 and -40,135.71% for Q4 2022.